Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.
about
Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Viral profiling identifies multiple subtypes of Kaposi's sarcoma.Human herpesviruses 6, 7, and 8 from a dermatologic perspective.Oral HHV-8 replication among women in Mombasa, KenyaHigher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia.Building capacity for sustainable research programmes for cancer in Africa.Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men.Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons.Cancer prevention in HIV-infected populations.Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants.Population-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among UgandansAnogenital Lesions: Kaposi's Sarcoma and Its Mimicks.Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisitionHuman herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment.Oral HIV-associated Kaposi sarcoma.Dynamics of Persistent Oral Cytomegalovirus Shedding During Primary Infection in Ugandan Infants.Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings.Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia.Predictors of seropositivity for human herpesvirus type 8 in patients with mild cirrhosis.Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.Prospective study of human herpesvirus 8 oral shedding, viremia, and serological status among human immunodeficiency virus seropositive and seronegative individuals in Sao Paulo, Brazil.Identifying predictors of increased quantities of human Herpesvirus 8 DNA detection at oropharyngeal and plasma sites among Ugandan adults with and without HIV and Kaposi Sarcoma.Omega-3 decreases interleukin-6 levels in HIV and HHV-8 co-infected patients: results from a randomized supplementation trial in Uganda.KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite.
P2860
Q30396626-157AC144-7FD8-41D9-B774-B215F3BB89FFQ33610926-0E2B5A22-55BA-4C8D-AE85-0FFED57B5295Q33798426-49E4E6BA-ADCB-41BB-8229-8442ACAA7993Q34237734-34FCD183-2DCD-4E04-A451-12B4154FFD85Q34346918-50F516B6-1F9D-4301-8A09-B690CFA4C426Q34901897-4D5FF0D6-7675-4B4E-A968-85000638815AQ34963626-AA9C90D5-6E55-4370-B0EA-F6B103EC6A11Q35492988-C773748D-A2E6-48DB-9735-B8043783EB7AQ36301349-4027762F-43B1-4F55-9C80-3776B72A6FE9Q36565716-FA4F9124-9B2C-4BA9-9872-14B914AB02C8Q36680086-30B4505B-93C7-4F35-9E4F-BFE3AEA550F7Q37003029-F29C6657-7C41-4A7A-8841-19325D492C6CQ37128291-468D502A-8D5F-4C0E-851B-4C6FD17993A4Q37156859-92D11927-3696-4FB4-9488-69B297F8445AQ37295563-F43D8E23-F358-4F0E-9CE6-3AE14DA44CB6Q37888397-81D9263D-17FF-407F-876B-F169FCA4D19CQ38016546-8C9819FF-AD2B-4AD8-BF84-0CF9805A7B26Q38852952-D63570C9-AD3A-4A45-838E-1AB1F05B7E46Q38898426-851002CC-7CB4-45C3-B8B9-ED4DE4FEF021Q40042151-E969ED07-4F50-4A1C-979E-00DBEEE356F9Q40170202-7DF6A0FC-CD05-4761-AE1D-83CD4A5E6C32Q42710842-3CDDE82B-BE05-4E78-8BB3-702B0E7121D3Q45325522-7B2A8F5B-9EAB-40CB-A269-4FF9044C6002Q46052064-FB24F995-A396-4626-A305-11C22E2CACBAQ46757056-8E55DAFF-0335-418B-A604-96DC6F812969Q50099317-F29C99C2-4277-4871-B33F-C0EA1685A7AA
P2860
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@ast
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@en
type
label
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@ast
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@en
prefLabel
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@ast
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@en
P2093
P2860
P50
P1433
P1476
Impact of HIV infection and Ka ...... n and dissemination in Uganda.
@en
P2093
Corey Casper
Edward Katongole-Mbidde
Fred Okuku
Jackson Orem
Keith McAdam
Linda Drolette
Mary Kalinaki
Merle Sande
Misty Saracino
Stacy Selke
P2860
P356
10.1371/JOURNAL.PONE.0004222
P407
P577
2009-01-20T00:00:00Z